Leading causes of death after a diagnosis of endometrial cancer: a systematic review and meta-analysis.

IF 4.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Heather J Agnew, Holly Baker-Rand, Sarah J Kitson, Emma J Crosbie
{"title":"Leading causes of death after a diagnosis of endometrial cancer: a systematic review and meta-analysis.","authors":"Heather J Agnew, Holly Baker-Rand, Sarah J Kitson, Emma J Crosbie","doi":"10.1016/j.ijgc.2025.101926","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Despite curative treatment, an endometrial cancer (EC) diagnosis is associated with an elevated risk of death compared with age-matched women in the general population. This study aimed to quantify their risk of death from EC, cardiovascular disease, and other causes.</p><p><strong>Methods: </strong>A systematic review of Medline, Embase, and CENTRAL databases was performed to February 2024. Studies reporting cause of death after a diagnosis of EC were included. Mortality rates and 95% CIs were calculated using a random-effects model. Heterogeneity was assessed through visual inspection of forest plots and the I<sup>2</sup> statistic. Risk of bias and evidence quality were appraised using the Newcastle-Ottawa scale and Grading of Recommendations Assessment, Development and Evaluation (GRADE), respectively. The effect of ethnicity, stage, grade, and time from diagnosis was examined.</p><p><strong>Results: </strong>In total, 22 studies including 323,551 participants were analyzed and 102,711 (31.7%) died within 20 years of diagnosis, 62.6% (n = 64,155) from non-EC causes. In the 12 studies that reported cardiovascular death, 24.6% of participants (n = 24,309) died from cardiovascular disease. Those with local disease at presentation were more likely to die from non-EC causes than those with advanced disease at presentation (48.9% vs 13.5%). A total of 2 studies reported cause of death by ethnicity; overall, Black individuals were more likely to die than individuals of White or Other ethnicities (40.8% vs 27.9% vs 18.9%). Deaths related to non-EC causes, including cardiovascular disease, overtook EC-specific deaths >5 years after diagnosis. Significant heterogeneity was noted, despite sub-group analyses, and the findings were based on very low certainty evidence.</p><p><strong>Conclusions: </strong>Individuals with a history of EC are at increased risk of death from other causes. Oncology follow-up appointments provide the ideal opportunity to optimize cardiovascular risk factors to reduce preventable deaths. Future research needs to reflect the global majority.</p>","PeriodicalId":14097,"journal":{"name":"International Journal of Gynecological Cancer","volume":"35 7","pages":"101926"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gynecological Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijgc.2025.101926","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Despite curative treatment, an endometrial cancer (EC) diagnosis is associated with an elevated risk of death compared with age-matched women in the general population. This study aimed to quantify their risk of death from EC, cardiovascular disease, and other causes.

Methods: A systematic review of Medline, Embase, and CENTRAL databases was performed to February 2024. Studies reporting cause of death after a diagnosis of EC were included. Mortality rates and 95% CIs were calculated using a random-effects model. Heterogeneity was assessed through visual inspection of forest plots and the I2 statistic. Risk of bias and evidence quality were appraised using the Newcastle-Ottawa scale and Grading of Recommendations Assessment, Development and Evaluation (GRADE), respectively. The effect of ethnicity, stage, grade, and time from diagnosis was examined.

Results: In total, 22 studies including 323,551 participants were analyzed and 102,711 (31.7%) died within 20 years of diagnosis, 62.6% (n = 64,155) from non-EC causes. In the 12 studies that reported cardiovascular death, 24.6% of participants (n = 24,309) died from cardiovascular disease. Those with local disease at presentation were more likely to die from non-EC causes than those with advanced disease at presentation (48.9% vs 13.5%). A total of 2 studies reported cause of death by ethnicity; overall, Black individuals were more likely to die than individuals of White or Other ethnicities (40.8% vs 27.9% vs 18.9%). Deaths related to non-EC causes, including cardiovascular disease, overtook EC-specific deaths >5 years after diagnosis. Significant heterogeneity was noted, despite sub-group analyses, and the findings were based on very low certainty evidence.

Conclusions: Individuals with a history of EC are at increased risk of death from other causes. Oncology follow-up appointments provide the ideal opportunity to optimize cardiovascular risk factors to reduce preventable deaths. Future research needs to reflect the global majority.

子宫内膜癌诊断后的主要死亡原因:系统回顾和荟萃分析。
目的:尽管治疗有效,子宫内膜癌(EC)诊断与普通人群中年龄匹配的女性相比,死亡风险升高相关。本研究旨在量化他们死于EC、心血管疾病和其他原因的风险。方法:对截至2024年2月的Medline、Embase和CENTRAL数据库进行系统评价。研究报告了诊断为EC后的死亡原因。使用随机效应模型计算死亡率和95% ci。通过目视检验和I2统计量评估异质性。偏倚风险和证据质量分别采用纽卡斯尔-渥太华量表和建议评估、发展和评价分级(GRADE)进行评价。检查种族、分期、分级和诊断时间的影响。结果:总共分析了22项研究,包括323,551名参与者,102,711人(31.7%)在诊断20年内死亡,62.6% (n = 64,155)死于非ec原因。在12项报告心血管死亡的研究中,24.6%的参与者(n = 24,309)死于心血管疾病。发病时有局部疾病的患者比发病时有晚期疾病的患者更有可能死于非ec原因(48.9% vs 13.5%)。共有2项研究报告了按种族划分的死亡原因;总体而言,黑人比白人或其他种族的人更容易死亡(40.8%比27.9%比18.9%)。与非ec原因相关的死亡,包括心血管疾病,在诊断后5年超过了ec特异性死亡。尽管进行了亚组分析,但仍注意到显著的异质性,并且研究结果基于非常低的确定性证据。结论:有EC病史的个体因其他原因死亡的风险增加。肿瘤随访预约为优化心血管危险因素以减少可预防的死亡提供了理想的机会。未来的研究需要反映全球大多数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.60
自引率
10.40%
发文量
280
审稿时长
3-6 weeks
期刊介绍: The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信